HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (9H- fluoren- 9- ylethoxycarbonyl)- 4- aminobenzoic acid

inhibits leukocyte infiltration

Also Known As:

NPC 16570; NPC-16570; Benzoic acid, 4-(((2-(9H-fluoren-9-yl)ethoxy)carbonyl)amino)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/01/1993 - "Prevention and suppression of experimental allergic encephalomyelitis by an orally active leukocyte recruitment inhibitor, NPC 16570." 01/01/1993 - "An orally active leukocyte recruitment inhibitor, NPC 16570 (N-[9H-fluoren-9-ylethoxycarbonyl]-4-aminobenzoic acid), was evaluated in experimental allergic encephalomyelitis (EAE) in rats. "
2.	Autoimmune Diseases (Autoimmune Disease) 01/01/1993 - "When NPC 16570 (100 mg/kg) treatment was initiated 7 days after EAE induction, the severity (75% inhibition) and duration of the disease were attenuated; 2 out of 6 animals showed no overt clinical symptoms and perivascular cell infiltration was prevented, suggesting potential utility in autoimmune diseases."

Related Drugs and Biologics

1.	4-Aminobenzoic Acid (4 Aminobenzoic Acid)